Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 3342

BillFederalSenateIn Committee
A bill to amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes.
About This Bill
Committee
Latest Action · February 27, 2020
Read twice and referred to the Committee on the Judiciary.
Congress
116th (2019–2021)
Introduced
February 27, 2020
Cosponsors (2)
0D 2R
View PDF ↗

Summary

Highlight any text to annotate
Zero Tolerance for Deceptive Fentanyl Trafficking Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.